Literature DB >> 15487110

Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome.

Garth H Ballantyne1, Jonathan Svahn, Rafael F Capella, Joseph F Capella, Hans J Schmidt, Annette Wasielewski, Richard J Davies.   

Abstract

BACKGROUND: The number of weight reduction operations performed for type II and type III obesity is rapidly escalating. Risk of surgery has been infrequently stratified for patient subgroups. The purpose of this study was to identify patient characteristics that increased the odds of a prolonged hospital length of stay (LOS) following open or laparoscopic Roux-en-Y gastric bypass (RYGBP).
METHODS: The hospital records of 311 patients who underwent RYGBP in a 6-month period were retrospectively reviewed. Patient characteristics including the presence of significant obesity-related medical conditions were recorded. Analysis was based on intent to treat. Univariate and step-wise logistic regression analysis was used to identify the odds ratio (OR) and adjusted odds ratio (AOR) for predictors of an increased hospital LOS.
RESULTS: Datasets for 311 patients were complete.159 patients underwent open vertical banded gastro-plasty-Roux-en-Y gastric bypass (VBG-RYGBP) and152 laparoscopic RYGBP (LRYGBP). 78% of patients were female. Median age was 40 years (range 18-68). Median BMI was 49 kg/m2 (range 35-82). 17% of patients had sleep apnea, 18% asthma, 19% type 2 diabetes, 13% hypercholesterolemia and 44% hypertension. Median length of surgery for open VBG-RYGBP (64 minutes) was significantly faster than forLRYGBP (105 minutes). Median length of stay was significantly shorter for LRYGBP (2 days) than openVBG-RYGBP (3 days). Univariate logistic regression analysis identified 6 predictors of increased LOS:open surgery (0.4 OR); increasing BMI (60 kg/m2 0.38 OR; BMI 70 kg/m2 0.53 OR); increasing length of surgery (120 min 0.33 OR; 180 min 0.48 OR); sleep apnea (2.25 OR); asthma (3.73 OR); and hypercholesterolemia (3.73 OR). Subset analysis identified patients with the greatest odds for a prolonged hospital stay: women with asthma (2.47 AOR) or coronary artery disease (8.65 AOR); men with sleep apnea (5.54 OR) or the metabolic syndrome (6.67-10.20 OR); and patients undergoing a laparoscopic operation with sleep apnea (11.53 AOR) or coronary artery disease(12.15 AOR).
CONCLUSIONS: Open surgery, BMI, length of surgery,sleep apnea, asthma and hypercholesterolemia all increased the odds of a prolonged LOS. Patients with the greatest odds of long LOS were women with asthma or coronary disease, men with sleep apnea or the metabolic syndrome, and patients undergoing laparoscopic surgery with sleep apnea or coronary artery disease. Patients at high-risk for prolonged hospital stay can be identified before undergoingRYGBP. Surgeons may wish to avoid high-risk patients early in their bariatric surgery experience.

Entities:  

Mesh:

Year:  2004        PMID: 15487110     DOI: 10.1381/0960892041975460

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

Review 1.  Challenges in pulmonary risk assessment and perioperative management in bariatric surgery patients.

Authors:  Roop Kaw; Loutfi Aboussouan; Dennis Auckley; Charles Bae; David Gugliotti; Paul Grant; Wael Jaber; Philip Schauer; Daniel Sessler
Journal:  Obes Surg       Date:  2007-11-16       Impact factor: 4.129

2.  Bariatric surgery: severity, level of control, and time required for preoperative asthma control.

Authors:  Saulo Maia d'Avila Melo
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

Review 3.  Nutrition, Physical Activity, and Prescription of Supplements in Pre- and Post-bariatric Surgery Patients: a Practical Guideline.

Authors:  Mastaneh Rajabian Tabesh; Faezeh Maleklou; Fatemeh Ejtehadi; Zahra Alizadeh
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

4.  Determinants of resource utilization and outcomes in laparoscopic Roux-en-Y gastric bypass: a multicenter analysis of 14,251 patients.

Authors:  Prateek K Gupta; Weldon J Miller; Jyothsna Sainath; R Armour Forse
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

5.  Management plan to reduce risks in perioperative care of patients with presumed obstructive sleep apnea syndrome.

Authors:  Bhargavi Gali; Francis X Whalen; Peter C Gay; Eric J Olson; Darrell R Schroeder; David J Plevak; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

6.  Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study.

Authors:  B Coffin; V Maunoury; F Pattou; X Hébuterne; S Schneider; M Coupaye; S Ledoux; F Iglicki; F Mion; M Robert; E Disse; J Escourrou; G Tuyeras; Y Le Roux; C Arvieux; P Pouderoux; N Huten; T Alfaiate; D Hajage; S Msika
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

7.  Prevalence and severity of sleep apnea in a group of morbidly obese patients.

Authors:  Carla Daltro; Paloma Baiardi Gregorio; Erivaldo Alves; Maurício Abreu; Daniel Bomfim; Maria Helena Chicourel; Leila Araújo; Helma P Cotrim
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

8.  Oximetry alone versus portable polygraphy for sleep apnea screening before bariatric surgery.

Authors:  Maude Malbois; Vittorio Giusti; Michel Suter; Cyril Pellaton; Jean-Frédéric Vodoz; Raphael Heinzer
Journal:  Obes Surg       Date:  2010-01-06       Impact factor: 4.129

9.  Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study.

Authors:  John A Batsis; Abel Romero-Corral; Maria L Collazo-Clavell; Michael G Sarr; Virend K Somers; Francisco Lopez-Jimenez
Journal:  Mayo Clin Proc       Date:  2008-08       Impact factor: 7.616

10.  The application of comorbidity indices to predict early postoperative outcomes after laparoscopic Roux-en-Y gastric bypass: a nationwide comparative analysis of over 70,000 cases.

Authors:  Jin Hee Shin; Mathias Worni; Anthony W Castleberry; Ricardo Pietrobon; Philip A Omotosho; Mina Silberberg; Truls Østbye
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.